TELEMEDICINE BUSINESS PLAN
Â
I. Executive Summary
Company Description
Company name: Not provided. We are a premier telemedicine platform launching in 2026 that delivers 24/7 on-demand medical consultations across the United States. We operate in the telehealth sector and provide secure video and phone visits connecting patients with board-certified healthcare professionals. Primary services cover acute common ailments, mental health, and specialized wellness. Our headquarters manages technology, marketing, and provider credentialing to ensure clinical quality and consistent service delivery. One-line: on-demand, board-certified care available any time, nationwide.
We run a lean, technology-driven model that scales through a network of contracted practitioners and emphasizes patient convenience, transparent pricing, and clinical standards. Key activities: platform development, provider contracting and credentialing, patient intake and scheduling, secure telehealth visits, and billing. Target market: U.S. adults and families seeking fast access to primary acute care, behavioral health, and wellness services. Short-term goal: launch operations and achieve initial patient volume in 2026. Long-term goal: nationwide scale with specialty care expansion and sustained quality metrics. One-line: scaleable, quality-focused telemedicine with clear pricing and 24/7 access.
Â
Problem
Patients face long appointment wait times, travel burdens, exposure to other illnesses in waiting rooms, and scheduling conflicts that prevent timely care—especially busy professionals, parents, and rural residents. Delayed treatment raises out-of-pocket costs and system costs and can worsen conditions; one clear need is immediate access to care.
The market currently lacks a 24/7 on-demand solution that delivers immediate access to board-certified professionals via secure video and phone, leaving gaps in timely primary care, common-ailment treatment, mental health access, and specialist availability for rural areas.
Â
Solution
U.S. patients face long waits, travel burdens, limited rural access, and scheduling conflicts that lead to untreated common ailments and unnecessary emergency-room use. Our service addresses those gaps with a HIPAA-compliant, on-demand telemedicine platform offering 24/7 video, phone, and secure messaging visits with licensed General Physicians, Pediatricians, Dermatologists, Psychiatrists, and Nutritionists.
One-liner: Fast, secure telemedicine that connects patients to licensed clinicians and e-prescriptions any time.
Â
Mission Statement
Our mission is to democratize access to high-quality healthcare across the U.S. by removing the barriers of time, distance, and cost through secure, user-centered virtual care. We will serve as the most trusted and convenient first point of contact for non-emergency medical needs, combining advanced technology with a compassionate network of licensed providers. We commit to clinical excellence, patient privacy, and a seamless experience that empowers people to manage their health and improve outcomes.
Â
Key Success Factors
Critical operational and product checkpoints that determine whether the telemedicine model hits its financial and service targets.
-
Scale practitioner network to 116 providers by 2030 while maintaining 24/7 coverage.
-
Maintain intuitive, HIPAA-compliant platform to protect PHI and sustain user retention.
-
Achieve 80% capacity utilization for General Physicians to meet revenue and margin targets.
-
Secure long-term corporate employer partnerships to generate stable, high-volume revenue.
-
Keep lean cost structure on payouts and marketing to reach $17,022,000 EBITDA by Year 5.
Financial Summary
Brief financial snapshot: launch in 2026, minimum cash reserve $661,000, breakeven Jan 2027, strong EBITDA growth and investor returns.
Â
Ratio |
2026 |
2027 |
2028 |
Projected Revenue |
$2,300,400 |
$4,825,380 |
$9,479,760 |
Projected EBITDA |
-$20,000 |
$1,053,000 |
$4,024,000 |
Expected ROI |
IRR 13%; ROE 33.45% |
IRR 13%; ROE 33.45% |
IRR 13%; ROE 33.45% |
Â
Financial requirements: Maintain minimum cash of $661,000 through Dec 2026 to cover capex and operating ramp; expected investor return based on IRR 13% and ROE 33.45% with payback in 18 months.
Overall outlook: profitable by Jan 2027 and scaling to multi‑million EBITDA by Year 3–5.
Â
Funding Requirements
We require capital to cover 2026 capex and launch losses so the telemedicine service reaches breakeven in January 2027 and scales to projected EBITDA of $1,053,000 in Year 2 and $17,022,000 in Year 5.
Â
Categories |
Amount, USD |
Initial Platform Development |
150,000 |
Core IT Infrastructure |
30,000 |
HIPAA Compliant Data Storage Setup |
25,000 |
Telehealth Equipment Diagnostic Kits |
18,000 |
Brand Identity & Website Design |
20,000 |
Remote Workstation Setup (initial team) |
12,000 |
Initial Marketing & Analytics Licenses |
10,000 |
Legal Entity & Initial Compliance Setup |
15,000 |
HIPAA Compliance Software (annual) |
14,400 |
Executive & Lead-level Salaries (Year 1) |
425,000 |
Operating losses to breakeven (Year 1 EBITDA) |
20,000 |
Staffing — recruitment of 13 healthcare professionals |
0 |
Working capital |
661,000 |
Total funding required |
1,400,400 |
Â